JP2021514945A5 - - Google Patents
Info
- Publication number
- JP2021514945A5 JP2021514945A5 JP2020543140A JP2020543140A JP2021514945A5 JP 2021514945 A5 JP2021514945 A5 JP 2021514945A5 JP 2020543140 A JP2020543140 A JP 2020543140A JP 2020543140 A JP2020543140 A JP 2020543140A JP 2021514945 A5 JP2021514945 A5 JP 2021514945A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- pharmaceutical composition
- composition according
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023138517A JP2023159403A (ja) | 2018-02-26 | 2023-08-29 | がんを治療するための、化学療法剤と併用した多量体抗ｄｒ５結合分子の使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635033P | 2018-02-26 | 2018-02-26 | |
| US62/635,033 | 2018-02-26 | ||
| US201862767900P | 2018-11-15 | 2018-11-15 | |
| US62/767,900 | 2018-11-15 | ||
| PCT/US2019/019340 WO2019165340A1 (en) | 2018-02-26 | 2019-02-25 | Use of a multimeric anti-dr5 binding molecule in combination with a chemotherapeutic agent for treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023138517A Division JP2023159403A (ja) | 2018-02-26 | 2023-08-29 | がんを治療するための、化学療法剤と併用した多量体抗ｄｒ５結合分子の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514945A JP2021514945A (ja) | 2021-06-17 |
| JP2021514945A5 true JP2021514945A5 (https=) | 2022-02-18 |
| JP7358365B2 JP7358365B2 (ja) | 2023-10-10 |
Family
ID=67688449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543140A Active JP7358365B2 (ja) | 2018-02-26 | 2019-02-25 | がんを治療するための、化学療法剤と併用した多量体抗ｄｒ５結合分子の使用 |
| JP2023138517A Pending JP2023159403A (ja) | 2018-02-26 | 2023-08-29 | がんを治療するための、化学療法剤と併用した多量体抗ｄｒ５結合分子の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023138517A Pending JP2023159403A (ja) | 2018-02-26 | 2023-08-29 | がんを治療するための、化学療法剤と併用した多量体抗ｄｒ５結合分子の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200392239A1 (https=) |
| EP (1) | EP3759229A4 (https=) |
| JP (2) | JP7358365B2 (https=) |
| KR (1) | KR20200123782A (https=) |
| CN (1) | CN111757941A (https=) |
| AU (1) | AU2019224136A1 (https=) |
| CA (1) | CA3091140A1 (https=) |
| WO (1) | WO2019165340A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3105250B1 (en) | 2014-02-10 | 2020-08-05 | IGM Biosciences, Inc. | Iga multi-specific binding molecules |
| PL3560954T3 (pl) | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| EP3957738A1 (en) | 2015-03-04 | 2022-02-23 | IGM Biosciences, Inc. | Cd20 binding molecules and uses thereof |
| WO2016154593A1 (en) | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| CN107847591B (zh) | 2015-04-17 | 2023-07-28 | Igm生物科学股份有限公司 | 多价人免疫缺陷病毒抗原结合分子及其应用 |
| EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| EP3355913B1 (en) | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| SG11201809336QA (en) | 2016-05-09 | 2018-11-29 | Igm Biosciences Inc | Anti-pd-l1 antibodies |
| MX2019011986A (es) | 2017-04-07 | 2019-11-07 | Igm Biosciences Inc | Regiones constantes de igm humana modificadas para la modulacion de la funcion efectora de la citolisis dependiente de complemento referencia cruzada a solicitudes relacionadas. |
| MX2020009069A (es) | 2018-03-01 | 2020-10-08 | Igm Biosciences Inc | Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero. |
| JP2022544405A (ja) | 2019-08-15 | 2022-10-18 | アイジーエム バイオサイエンシズ インコーポレイテッド | 免疫刺激性多量体型結合分子 |
| EP4139362A2 (en) | 2020-04-22 | 2023-03-01 | IGM Biosciences Inc. | Pd-1 agonist multimeric binding molecules |
| JP2023526224A (ja) * | 2020-05-12 | 2023-06-21 | アイジーエム バイオサイエンシズ インコーポレイテッド | がんを治療するための、がん治療薬との組合せでの多量体抗ｄｒ５結合分子の使用 |
| EP4277706A1 (en) * | 2021-01-15 | 2023-11-22 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Inducers of senescence, in combination with a selective death receptor 5 (dr5) agonist, for use in a method of treating cancer |
| US12600801B2 (en) | 2022-07-11 | 2026-04-14 | Fred Hutchinson Cancer Center | Single-domain antibodies that bind ROR1 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080248046A1 (en) * | 1997-03-17 | 2008-10-09 | Human Genome Sciences, Inc. | Death domain containing receptor 5 |
| CN100427505C (zh) * | 2004-08-19 | 2008-10-22 | 中国医学科学院基础医学研究所 | 抗人肿瘤坏死因子相关凋亡诱导配体的受体dr5单克隆抗体（ad5-10）及其制法与用途 |
| PE20071101A1 (es) | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| WO2008066854A2 (en) * | 2006-11-28 | 2008-06-05 | Novartis Ag | Methods and compositions for inducing apoptosis in cancer cells |
| CA2695991A1 (en) | 2007-08-09 | 2009-02-12 | Daiichi Sankyo Company, Limited | Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| PH12013500845A1 (en) | 2010-10-29 | 2013-06-24 | Daiichi Sankyo Co Ltd | Novel anti-dr5 antibody |
| EP2760891B1 (en) | 2011-09-26 | 2018-11-07 | JN Biosciences LLC | Hybrid constant regions |
| EP2684896A1 (en) | 2012-07-09 | 2014-01-15 | International-Drug-Development-Biotech | Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof |
| WO2014159562A1 (en) * | 2013-03-14 | 2014-10-02 | Bristol-Myers Squibb Company | Combination of dr5 agonist and anti-pd-1 antagonist and methods of use |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
-
2019
- 2019-02-25 EP EP19757688.7A patent/EP3759229A4/en not_active Withdrawn
- 2019-02-25 US US16/975,438 patent/US20200392239A1/en not_active Abandoned
- 2019-02-25 CA CA3091140A patent/CA3091140A1/en active Pending
- 2019-02-25 JP JP2020543140A patent/JP7358365B2/ja active Active
- 2019-02-25 CN CN201980014868.8A patent/CN111757941A/zh active Pending
- 2019-02-25 AU AU2019224136A patent/AU2019224136A1/en not_active Abandoned
- 2019-02-25 KR KR1020207023440A patent/KR20200123782A/ko not_active Ceased
- 2019-02-25 WO PCT/US2019/019340 patent/WO2019165340A1/en not_active Ceased
-
2023
- 2023-08-29 JP JP2023138517A patent/JP2023159403A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514945A5 (https=) | ||
| TWI457346B (zh) | 包含專一性辨識ｃｄ３８之抗體及環磷醯胺（ｃｙｃｌｏｐｈｏｓｐｈａｍｉｄｅ）之抗腫瘤組合 | |
| JP2021527431A5 (https=) | ||
| CN104684552B (zh) | 组合及其用途 | |
| JP2020527332A5 (https=) | ||
| JP2022510964A5 (https=) | ||
| JP2022515077A5 (https=) | ||
| HRP20220014T1 (hr) | Postupci liječenja raka kože davanjem inhibitora pd-1 | |
| JP2019519499A5 (https=) | ||
| CN111132696B (zh) | Pd-1抗体和表观遗传调节剂联合在制备治疗肿瘤的药物中的用途 | |
| FI3810281T3 (fi) | Menetelmiä syövän hoitamiseksi bispesifisillä anti-CD3XMUC16-vasta-aineilla ja anti-PD-1-vasta-aineilla | |
| HRP20231156T1 (hr) | Kombinacija anti-pd-1 antitijela i bispecifičnih anti-cd20/anti-cd3 antitijela za liječenje raka | |
| JP2018500014A5 (https=) | ||
| JP2019515008A5 (https=) | ||
| JP2013520442A5 (https=) | ||
| JP2018512435A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| JP2016519650A5 (https=) | ||
| JP2022512750A5 (https=) | ||
| JP2023526224A5 (https=) | ||
| JP2022512905A5 (https=) | ||
| JP2020515577A5 (https=) | ||
| JP2022512851A5 (https=) | ||
| CN107921129A (zh) | 组合及其用途 | |
| JP2023155262A (ja) | プレクチン１結合抗体およびその使用 |